Integrated precision medicine: the role of electronic health records in delivering personalized treatment

Wiley Interdisciplinary Reviews: Systems Biology and Medicine

Volumn 9, Issue 3, 2017, Pages

  Sitapati, Amy ^a,b,c   Kim, Hyeoneui ^a,b,c   Berkovich, Barbara ^b   Marmor, Rebecca ^a,b,c   Singh, Siddharth ^a,b,c   El Kareh, Robert ^a,b,c   Clay, Brian ^a,b,c   Ohno Machado, Lucila ^a,b,c,d  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO HEALTH SYSTEM   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d VA San Diego Health System   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DECISION SUPPORT SYSTEM; DIAGNOSIS; ELECTRONIC HEALTH RECORD; HEALTH CARE SYSTEM; HUMAN; PERSONALIZED MEDICINE; CLINICAL DECISION SUPPORT SYSTEM; INTEGRATED HEALTH CARE SYSTEM; MEDICAL INFORMATION SYSTEM;

DECISION SUPPORT SYSTEMS, CLINICAL; DELIVERY OF HEALTH CARE, INTEGRATED; ELECTRONIC HEALTH RECORDS; HEALTH INFORMATION EXCHANGE; HUMANS; PRECISION MEDICINE;

EID: 85013347498     PISSN: 19395094     EISSN: 1939005X     Source Type: Journal    
DOI: 10.1002/wsbm.1378     Document Type: Article

References (51)

1. Greenes RA. Features of computer-based clinical decision support. In: Greenes RA, ed. Clinical Decision Support: The Road to Broad Adoption. 2nd ed. Amsterdam, Nethelands: Elsevier; 2014.
2. Hamelinck VC, Bastiaannet E, Pieterse AH, de Glas NA, Portielje JE, Merkus JW, den Hoed ID, van de Velde CJ, Liefers G-J, Stiggelbout AM. A prospective comparison of younger and older patients' preferences for adjuvant chemotherapy and hormonal therapy in early breast cancer. Clin Breast Cancer 2016, 16.
3. Hassett MJ, O'Malley AJ, Pakes JR, Newhouse JP, Earle CC. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 2006, 98:1108–1117.
4. Early Breast Cancer Trialists’ Collaborative Group (EBCTCG). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005, 365:1687–1717.
5. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Breast Cancer [Internet]. Version 1. 2016 [2016]. pp. 1–191. Available at: https://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
6. Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J. Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor–positive breast cancer. J Clin Oncol 2006, 24:3726–3734.
7. Joh JE, Esposito NN, Kiluk JV, Laronga C, Lee MC, Loftus L, Soliman H, Boughey JC, Reynolds C, Lawton TJ. The effect of oncotype DX recurrence score on treatment recommendations for patients with estrogen receptor–positive early stage breast cancer and correlation with estimation of recurrence risk by breast cancer specialists. Oncologist 2011, 16:1520–1526.
8. Adler-Milstein J, DesRoches CM, Kralovec P, Foster G, Worzala C, Charles D, Searcy T, Jha AK. Electronic health record adoption in US hospitals: progress continues, but challenges persist. Health Aff 2015, 34:2174–2180. doi:10.1377/hlthaff.2015.0992.
9. HealthIT.gov. Clinical Decision Support (CDS) 2016. Available at: https://www.healthit.gov/policy-researchershyphen;implementers/clinical-decision-support-cds (Accessed June 28, 2016).
10. de Keizer NF, Abu-Hanna A, Zwetsloot-Schonk J. Understanding terminological systems I: terminology and typology. Methods Inf Med 2000, 39:16–21.
11. Saitwal H, Qing D, Jones S, Bernstam EV, Chute CG, Johnson TR. Cross-terminology mapping challenges: a demonstration using medication terminological systems. J Biomed Inform 2012, 45:613–625.
12. HealthIT.gov. Title XIII-Health Information Technology 2009.
13. Waldren S, Kibbe D, Mitchell J. “Will the feds really buy me an EHR?” and other commonly asked questions about the HITECH Act. Fam Pract Manag 2009, 16:19–23.
14. Easterly E. Medicaid meaningful use incentives. J Ark Med Soc 2016, 112:204–205.
15. Resnick C, Meara J, Peltzman M, Gilley M. Meaningful use: a program in transition. Bull Am Coll Surg 2016, 101:10.
16. Vest JR, Gamm LD. Health information exchange: persistent challenges and new strategies. J Am Med Inform Assoc 2010, 17:288–294.
17. Gaynor M, Lenert L, Wilson KD, Bradner S. Why common carrier and network neutrality principles apply to the Nationwide Health Information Network (NWHIN). J Am Med Inform Assoc 2014, 21:2–7.
18. Williams C, Mostashari F, Mertz K, Hogin E, Atwal P. From the Office of the National Coordinator: the strategy for advancing the exchange of health information. Health Aff 2012, 31:527–536.
19. Thorn SA, Carter MA, Bailey JE. Emergency physicians’ perspectives on their use of health information exchange. Ann Emerg Med 2014, 63:329–337.
20. Mac McCullough J, Zimmerman FJ, Bell DS, Rodriguez HP. Electronic health information exchange in underserved settings: examining initiatives in small physician practices & community health centers. BMC Health Serv Res 2014, 14:1.
21. Richardson J, Malhotra S, Kaushal R, Investigators wtH. A case report in health information exchange for inter-organizational patient transfers. Appl Clin Inform 2014, 5:642–650.
22. Hyppönen H, Reponen J, Lääveri T, Kaipio J. User experiences with different regional health information exchange systems in Finland. Int J Med Inform 2014, 83:1–18.
23. Cimino J, ed. Infobuttons: anticipatory passive decision support. AMIA Annu Symp Proc 2008, 1203–1204.
24. Osheroff JA, Teich JM, Levick D, Saldana L, Velasco F, Sittig D, Rogers KM, Jenders RA. Improving outcomes with clinical decision support: an implementer's guide. Chicago, IL: Healthcare Information and Management Systems Society (HIMSS) 2012.
25. Bates DW, Kuperman GJ, Wang S, Gandhi T, Kittler A, Volk L, Spurr C, Khorasani R, Tanasijevic M, Middleton B. Ten commandments for effective clinical decision support: making the practice of evidence-based medicine a reality. J Am Med Inform Assoc 2003, 10:523–530.
26. Ash JS, Sittig DF, Campbell EM, Guappone KP, Dykstra RH, eds. Some unintended consequences of clinical decision support systems. AMIA Annu Symb Proc 2007, 26–30.
27. Ballard DJ, Ogola G, Fleming NS, Stauffer BD, Leonard BM, Khetan R, Yancy CW. Impact of a standardized heart failure order set on mortality, readmission, and quality and costs of care. International J Qual Health Care 2010, 22:437–444.
28. Zeidan AM, Streiff MB, Lau BD, Ahmed SR, Kraus PS, Hobson DB, Carolan H, Lambrianidi C, Horn PB, Shermock KM. Impact of a venous thromboembolism prophylaxis “smart order set”: improved compliance, fewer events. Am J Hematol 2013, 88:545–549.
29. Awdishu L, Coates CR, Lyddane A, Tran K, Daniels CE, Lee J, El-Kareh R. The impact of real-time alerting on appropriate prescribing in kidney disease: a cluster randomized controlled trial. J Am Med Inform Assoc 2016, 23:609–616.
30. Paik S, Shak S, Tang G, Kim C, Baker J, Cronin M, Baehner FL, Walker MG, Watson D, Park T. A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 2004, 351:2817–2826.
31. Maviglia SM, Yoon CS, Bates DW, Kuperman G. KnowledgeLink: impact of context-sensitive information retrieval on clinicians’ information needs. J Am Med Inform Assoc 2006, 13:67–73.
32. Elkin PL, Liebow M, Bauer BA, Chaliki S, Wahner-Roedler D, Bundrick J, Lee M, Brown SH, Froehling D, Bailey K, et al. The introduction of a diagnostic decision support system (DXplain™) into the workflow of a teaching hospital service can decrease the cost of service for diagnostically challenging Diagnostic Related Groups (DRGs). Int J Med Inform 2010, 79:772–777.
33. John RM, Hall E, Bakken S. Use of the Isabel decision support system to improve diagnostic accuracy of pediatric nurse practitioner and family nurse practitioner students. NI 2012: In: Proceedings of the 11th International Congress on Nursing Informatics, Montreal, Canada International Congress in Nursing Informatics 23–27 June, 2012.
34. Vardell E, Bou-Crick C. VisualDx: a visual diagnostic decision support tool. Med Ref Serv Q 2012, 31:414–424.
35. Lindenauer PK, Normand SL, Drye EE, Lin Z, Goodrich K, Desai MM, Bratzler DW, O'Donnell WJ, Metersky ML, Krumholz HM. Development, validation, and results of a measure of 30-day readmission following hospitalization for pneumonia. J Hosp Med 2011, 6:142–150.
36. Rattanaumpawan P, Teeratorn N, Thamlikitkul V. A cluster-randomized controlled trial of the catheter reminder and evaluation program. Infect Control Hosp Epidemiol 2016, 37:231–233.
37. Farrugia DJ, Fischer TD, Delitto D, Spiguel LR, Shaw CM. Improved breast cancer care quality metrics after implementation of a standardized tumor board documentation template. J Oncol Pract 2015, 11:421–423.
38. Lamba S, Berlin A, Goett R, Ponce CB, Holland B, Walther S, Group ARCW. Assessing emotional suffering in palliative care: use of a structured note template to improve documentation. J Pain Symptom Manage 2016, 52:1–7.
39. Plaisant C, Mushlin R, Snyder A, Li J, Heller D, Shneiderman B. LifeLines: using visualization to enhance navigation and analysis of patient records. Proc AMIA Symp 1998:76–80.
40. Bashyam V, Hsu W, Watt E, Bui AA, Kangarloo H, Taira RK. Problem-centric organization and visualization of patient imaging and clinical data. Radiographics 2009, 29:331–343.
41. Ashley EA. Towards precision medicine. Nat Rev Genet 2016, 17:507–522.
42. Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, Shendure J. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet 2011, 12:745–755.
43. Camicia R, Winkler HC, Hassa PO. Novel drug targets for personalized precision medicine in relapsed/refractory diffuse large B-cell lymphoma: a comprehensive review. Mol Cancer 2015, 14:1.
44. Tenenbaum JD. Translational bioinformatics: past, present, and future. Genomics Proteomics Bioinformatics 2016, 14:31–41.
45. Collins FS, Varmus H. A new initiative on precision medicine. N Engl J Med 2015, 372:793–795.
46. Hripcsak G, Duke JD, Shah NH, Reich CG, Huser V, Schuemie MJ, Suchard MA, Park RW, Wong ICK, Rijnbeek PR. Observational Health Data Sciences and Informatics (OHDSI): opportunities for observational researchers. Stud Health Technol Inform 2015, 216:574.
47. FitzHenry F, Resnic F, Robbins S, Denton J, Nookala L, Meeker D, Ohno-Machado L, Matheny M. Creating a common data model for comparative effectiveness with the observational medical outcomes partnership. Appl Clin Inform 2015, 6:536–547.
48. Reisinger SJ, Ryan PB, O'Hara DJ, Powell GE, Painter JL, Pattishall EN, Morris JA. Development and evaluation of a common data model enabling active drug safety surveillance using disparate healthcare databases. J Am Med Inform Assoc 2010, 17:652–662.
49. Ogunyemi OI, Meeker D, Kim H-E, Ashish N, Farzaneh S, Boxwala A. Identifying appropriate reference data models for comparative effectiveness research (CER) studies based on data from clinical information systems. Med Care 2013, 51:S45–S52.
50. Observational Health Data Sciences and Informatics. OMOP Common Data Model V5.0.1 2014. Available at: http://www.ohdsi.org. (Accessed July 29, 2016).
51. D'Amore JD, Mandel JC, Kreda DA, Swain A, Koromia GA, Sundareswaran S, Alschuler L, Dolin RH, Mandl KD, Kohane IS, et al. Are meaningful use stage 2 certified EHRs ready for interoperability? Findings from the SMART C-CDA collaborative. J Am Med Inform Assoc 2014, 21:1060–1068.